TransEnterix (NYSEAMERICAN:TRXC) Trading Up 15.8%

Share on StockTwits

TransEnterix, Inc. (NYSEAMERICAN:TRXC) shares were up 15.8% on Wednesday . The company traded as high as $0.34 and last traded at $0.39, approximately 95,570 shares were traded during mid-day trading. A decline of 96% from the average daily volume of 2,281,946 shares. The stock had previously closed at $0.34.

TransEnterix (NYSEAMERICAN:TRXC) last posted its quarterly earnings results on Monday, March 16th. The medical instruments supplier reported ($0.83) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.65) by ($0.18). The firm had revenue of $0.69 million for the quarter, compared to analysts’ expectations of $0.60 million.

In other TransEnterix news, Director Andrea Biffi bought 151,219 shares of the business’s stock in a transaction that occurred on Monday, February 24th. The stock was bought at an average cost of $1.24 per share, for a total transaction of $187,511.56. Following the completion of the transaction, the director now owns 199,738 shares of the company’s stock, valued at approximately $247,675.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in TRXC. First Trust Advisors LP increased its stake in shares of TransEnterix by 89.1% in the third quarter. First Trust Advisors LP now owns 1,336,607 shares of the medical instruments supplier’s stock worth $828,000 after purchasing an additional 629,658 shares in the last quarter. Millennium Management LLC increased its stake in shares of TransEnterix by 761.5% in the third quarter. Millennium Management LLC now owns 516,881 shares of the medical instruments supplier’s stock worth $320,000 after purchasing an additional 456,881 shares in the last quarter. State Street Corp increased its stake in shares of TransEnterix by 3.2% in the third quarter. State Street Corp now owns 3,739,371 shares of the medical instruments supplier’s stock worth $2,318,000 after purchasing an additional 116,308 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in shares of TransEnterix in the fourth quarter worth $79,000. Finally, Virtu Financial LLC increased its stake in shares of TransEnterix by 348.2% in the fourth quarter. Virtu Financial LLC now owns 54,677 shares of the medical instruments supplier’s stock worth $81,000 after purchasing an additional 42,477 shares in the last quarter.

About TransEnterix (NYSEAMERICAN:TRXC)

TransEnterix, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe.

Further Reading: Why Invest in Dividend Achievers?

Receive News & Ratings for TransEnterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TransEnterix and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Mitchell Mcleod Pugh & Williams Inc. Has $252,000 Holdings in General Electric
Mitchell Mcleod Pugh & Williams Inc. Has $252,000 Holdings in General Electric
Mitchell Mcleod Pugh & Williams Inc. Acquires 500 Shares of Starbucks Co.
Mitchell Mcleod Pugh & Williams Inc. Acquires 500 Shares of Starbucks Co.
Bank of America  PT Lowered to $20.00 at UBS Group
Bank of America PT Lowered to $20.00 at UBS Group
IFM Investors Pty Ltd Sells 5,253 Shares of Walmart Inc
IFM Investors Pty Ltd Sells 5,253 Shares of Walmart Inc
Macquarie Group Ltd. Has $2.83 Million Position in Valero Energy Co.
Macquarie Group Ltd. Has $2.83 Million Position in Valero Energy Co.
Marquette Asset Management LLC Increases Stock Position in Boeing Co
Marquette Asset Management LLC Increases Stock Position in Boeing Co


© 2006-2020 Ticker Report